Clinical Trial Detail

NCT ID NCT03359850
Title Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

Advanced Solid Tumor

Therapies

Niraparib

Age Groups: adult senior

No variant requirements are available.